文献速递心外重症与机械循环支持

机械循环支持装置患者肝素诱导性血小板减少症的诊断

Diagnosing heparin-induced thrombocytopenia in mechanical circulatory support device patients.
PubMed 文献 · J Heart Lung Transplant · 2021-09-17

本研究回顾了2014年4月至2020年8月接受HIT检测的机械循环支持装置(MCSD)患者,评估了510份PF4 IgG ELISA结果。HIT确诊率为4.2%,低概率4T评分患者均无HIT,而高概率4T评分且PF4免疫分析OD>2.0的患者均确诊HIT。低概率4T评分患者中22%的检测出现假阳性,导致不必要的直接凝血酶抑制剂转换和出血等并发症。

要点

  • 低概率4T评分患者无HIT,高概率4T评分且PF4 OD>2.0者均确诊HIT。
  • 低概率4T评分患者中22%的PF4检测为假阳性,可导致不必要的抗凝转换。
  • 应遵循AS H指南以减少假阳性筛查带来的临床并发症。

核心结论

  • 在MCSD患者中,遵循AS H指南可改善临床结局,减少假阳性筛查相关并发症。

研究设计与样本

  • 回顾性数据review,纳入2014年4月至2020年8月接受HIT检测的MCSD患者,评估510份PF4 IgG ELISA结果。

主要发现

  • HIT确诊率为4.2%。
  • 非耐用装置患者HIT患病率5.3%,耐用装置2.9%,植入前1.3%,差异无统计学意义(p=0.26)。
  • 低概率4T评分患者均无HIT。
  • 高概率4T评分且PF4免疫分析OD>2.0的患者均确诊HIT。
  • 低概率4T评分患者中22%的检测为假阳性。

关键数值与推荐

  • 低概率4T评分患者无HIT,高概率4T评分且PF4 OD>2.0者均确诊HIT。
  • 低概率4T评分患者中22%的PF4检测出现假阳性。

临床怎么用

  • 应依据AS H指南使用4T评分和PF4免疫分析结果解读HIT检测,避免低概率4T评分患者中假阳性结果导致不必要的直接凝血酶抑制剂转换。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mechanical circulatory support device (MCSD) patients with positive heparin-induced thrombocytopenia (HIT) screening pose a unique challenge, as clinicians must make rapid decisions about their anticoagulation and whether they can safely undergo cardiopulmonary bypass. We identified screening practices at our institution and other institutions nationwide that differed from American Society of Hematology (ASH) guidelines. This discovery prompted a data review to confirm the applicability of guidelines to this unique population and to highlight complications of "gestalt" screening. METHODS: Our study included MCSD patients with HIT testing from April 2014 to August 2020. We evaluated 510 PF4 IgG ELISA results. RESULTS: HIT was confirmed in 4.2% of patients. There was an increased prevalence of HIT in patients with nondurable (5.3%) vs durable devices (2.9%) or those in the preimplantation setting (1.3%), however this difference was not statistically significant (p = 0.26). None of the patients with a low probability 4T Score had HIT. All patients with a high probability 4T Score and PF4 immunoassay OD >2.0 had HIT. False positive results occurred in 22% of assays ordered for patients with a low probability 4T Score. Twelve patients with a low probability 4T Score and a false positive immunoassay were switched to a direct thrombin inhibitor (DTI) while awaiting confirmatory results. Two patients experienced clinically significant bleeding after conversion to a DTI. An organ was refused in one patient with false positive HIT screening. CONCLUSIONS: Our findings demonstrate that an opportunity exists to improve clinical outcomes by re-emphasizing the utility of established guidelines and highlighting their safe use in the MCSD patient population.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Halprin C, Czer LS, Cole R, et al. Diagnosing heparin-induced thrombocytopenia in mechanical circulatory support device patients. J Heart Lung Transplant. 2021. PMID: 34656418. doi:10.1016/j.healun.2021.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。